Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jun;42(7):1052-61.
doi: 10.1007/s00259-015-3035-4. Epub 2015 Mar 20.

[(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease

Affiliations
Comparative Study

[(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease

Ryuichi Harada et al. Eur J Nucl Med Mol Imaging. 2015 Jun.

Abstract

Purpose: Visualization of the spatial distribution of neurofibrillary tangles would help in the diagnosis, prevention and treatment of dementia. The purpose of the study was to evaluate the clinical utility of [(18)F]THK-5117 as a highly selective tau imaging radiotracer.

Methods: We initially evaluated in vitro binding of [(3)H]THK-5117 in post-mortem brain tissues from patients with Alzheimer's disease (AD). In clinical PET studies, [(18)F]THK-5117 retention in eight patients with AD was compared with that in six healthy elderly controls. Ten subjects underwent an additional [(11)C]PiB PET scan within 2 weeks.

Results: In post-mortem brain samples, THK-5117 bound selectively to neurofibrillary deposits, which differed from the binding target of PiB. In clinical PET studies, [(18)F]THK-5117 binding in the temporal lobe clearly distinguished patients with AD from healthy elderly subjects. Compared with [(11)C]PiB, [(18)F]THK-5117 retention was higher in the medial temporal cortex.

Conclusion: These findings suggest that [(18)F]THK-5117 provides regional information on neurofibrillary pathology in living subjects.

PubMed Disclaimer

References

    1. J Neurosci. 2005 Nov 23;25(47):10857-62 - PubMed
    1. Biochem Pharmacol. 2014 Apr 15;88(4):529-39 - PubMed
    1. Arch Neurol. 1995 Jan;52(1):81-8 - PubMed
    1. Nat Rev Drug Discov. 2010 May;9(5):387-98 - PubMed
    1. Brain. 2014 Jun;137(Pt 6):1762-71 - PubMed

Publication types

MeSH terms

LinkOut - more resources